Springer Nature
Browse
13195_2018_459_MOESM2_ESM.docx (53.23 kB)

Additional file 2: of Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis

Download (53.23 kB)
journal contribution
posted on 2019-01-15, 05:00 authored by Lucilla Parnetti, Elena Chipi, Nicola Salvadori, Katia D’Andrea, Paolo Eusebi
Table S2. Cut-offs used for defining pre-clinical Alzheimer’s disease according biomarkers positivity. Table S3. Education years. (DOCX 53 kb)

History

Usage metrics

    Alzheimer's Research & Therapy

    Categories

    Keywords

    Preclinical Alzheimer’s diseaseSystematic reviewBiomarkersNational Institute on Aging–Alzheimer’s Association criteriaPrevalence

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC